Home/Filings/4/0000905148-25-001216
4//SEC Filing

Thompson Tommy G 4

Accession 0000905148-25-001216

CIK 0000025743other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 7:59 AM ET

Size

6.4 KB

Accession

0000905148-25-001216

Insider Transaction Report

Form 4
Period: 2025-04-14
Thompson Tommy G
DirectorOther
Transactions
  • Purchase

    Common Stock

    2025-04-14$1.00/sh+325$32614,779 total
Holdings
  • Common Stock

    (indirect: By LLC)
    14,312
  • Common Stock

    (indirect: By LLC)
    21
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.99 through $1.05, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.

Documents

1 file

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001324863

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:59 AM ET
Size
6.4 KB